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Background: Aging may contribute to decreased physical activity in chronic obstructive pulmonary dis-
ease (COPD). We explored the predictors of physical inactivity in older patients with COPD.
Methods: Thirty male patients with clinically stable COPD participated in the study (age 66.9  4.3 years,
forced expiratory volume in 1 second [FEV1, % of predicted] 52.6  24.6%). Patient characteristics were
recorded. Pulmonary function testing was performed and disease stage was determined using the Global
Initiative for Chronic Obstructive Pulmonary Disease (GOLD) classiﬁcation system. Maximal inspiratory
and expiratory muscle strength and quadriceps muscle strength were determined using a hand-held
device. Dyspnea perception was assessed using the modiﬁed Medical Research Council (MMRC) scale.
Functional capacity was evaluated using a 6-minute walk test (6MWT). Heart rate and oxygen saturation
were recorded before and after 6MWT. Physical activity was assessed using the International Physical
Activity Questionnaire (IPAQ).
Results: In elderly COPD patients, the IPAQ sitting score was signiﬁcantly related to 6MWT distance (r ¼
0.51), GOLD stage (r ¼ 0.52), paroxysmal nocturnal dyspnea (r ¼ 0.42) and orthopnea (r ¼ 0.50),
MMRC score (r ¼ 0.40), FEV1 (r ¼ 0.48), FEV1/forced vital capacity (FVC) (r ¼ 0.47), forced expiratory
ﬂow between 25% and 75% of FVC (r ¼ 0.43), peak expiratory ﬂow (r ¼ 0.43), baseline heart rate
(r ¼ 0.40), change in heart rate (r ¼ 0.46), and baseline oxygen saturation (r ¼ 0.43, p < 0.05). GOLD
stage, change in heart rate, and orthopnea independently predicted the IPAQ sitting score (R ¼ 0.732,
R2 ¼ 0.536, F(1,24) ¼ 4.769, p ¼ 0.039).
Conclusion: Disease severity, heart rate response to exercise, and orthopnea are determinants of physical
inactivity in elderly COPD.
Copyright  2013, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Chronic obstructive pulmonary disease (COPD) is characterized
by progressive airﬂow limitation. It is a major cause of morbidity,
prevalently affecting older people1e4. The severity of COPD in-
creases with advancing age1. Comorbidities and hospitalization5
are common in older patients with COPD1. Age-related changes in
pulmonary function6 and a compromised immune system1 result inerest.
of Physiotherapy and Reha-
iversity, 06100 Samanpazari,
).
iwan Society of Geriatric Emergenhigh mortality rates2. Improvements in COPD management can
increase survival despite severe disability and respiratory
impairment7.
Declining mobility is common in elderly individuals and is
associated with decreased pulmonary function and respiratory and
peripheral muscle strength6, and adverse health outcomes8. Func-
tional exercise capacity is also reduced in elderly patients with
COPD7. Physiological changes in COPD, including reduced body
weight, lean body mass2, pulmonary function9, peripheral and
respiratory muscle strength6, and reduced respiratory muscle
endurance10, are factors responsible for progressive impairment of
exercise tolerance1.
In addition to lower physical exercise capacity, physical inac-
tivity during everyday tasks is common in patients with COPD11.cy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
Table 1
Anthropometric and functional characteristics for COPD patients.
Mean  SD Range
Age (y) 66.87  4.31 61e78
Body mass index (kg/m2) 25.53  3.72 17.36e33.98
Time from diagnosis (y) 8.42  6.47 1e30
MMRC 1.73  0.91 0e3
FEV1 (%) 52.62  24.59 16e104
FVC (%) 68.79  21.74 38e113
FEV1/FVC 60.74  13.56 33.50e78.60
PEF (%) 57.28  27.28 20e128
FEF25e75% (%) 30.07  19.99 9e82
Smoking (pack-y) 47.76  27.10 1e110
6MWT distance (m) 497.72  118.28 171e655.6
HRmax (%) 72.58  10.78 51.61e99.33
BORG-dyspnea (0e10) 2.23  2.45 0e9
BORG-fatigue (0e10) 2.32  2.37 0e10
MIP (cmH2O) 86.66  28.23 22e153
MEP (cmH2O) 132.93  36.98 72e244
SpO2 (%) 94.37  2.44 89e99
Quadriceps muscle strength (N) 288.48  76.66 107.60e427.50
IPAQ total 1662.16  2370.99 149e12159
IPAQ sitting 583.45  205.29 180e960
BODE index (0e10) 2.59  2.10 0e8
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commonly used in assessment of physical activity since it has
acceptable measurement properties12. To the best of our knowl-
edge, there is a lack of studies investigating predictors of physical
inactivity in elderly patients with COPD. Since spending a large part
of the day in a sitting position is considered to be a characteristic of
the elderly13, we used the IPAQ sitting score to determine the level
of physical inactivity in elderly patients with COPD. The purpose of
this study was to investigate predictors of physical inactivity in
COPD patients with advancing age.
2. Methods
2.1. Patients
Thirty elderly male patients with COPD (61e78 years) partici-
pated in this study. The diagnosis of COPD by a pulmonologist was
based on medical history, current symptoms, and pulmonary func-
tion testing following Global Initiative for Chronic Obstructive Pul-
monary Disease (GOLD) guidelines14. All subjects had stable COPD at
the time of the study. Patient characteristics including age, height,
weight, time from diagnosis, and smoking history were recorded.
Body mass index was calculated as kg/m2. Subjects who had signif-
icant musculoskeletal or cardiovascular conditions were excluded.
All subjects provided written consent to participate in the study,
which was approved by the Hacettepe University Ethics Committee.
2.2. Measurements
2.2.1. Pulmonary function
Pulmonary function was tested using a spirometer (Spirolab;
Medical International Research, Rome, Italy). The highest value from
at least three technically acceptable maneuvers was expressed as a
percentage of the predicted values for forced vital capacity (FVC),
forced expiratory volume in 1 second (FEV1), peak expiratory ﬂow
rate (PEF), and forced expiratory ﬂow between 25% and 75% of FVC
(FEF25e75%)15.
2.2.2. Breathlessness
Functional dyspnea was measured using the modiﬁed Medical
Research Council (MMRC) dyspnea scale16. The scale consists of ﬁve
statements describing respiratory disability from none (score 0) to
almost complete incapacity (score 4). The score is the number that
best ﬁts the patient’s level of activity.
2.2.3. Respiratory muscle strength
Inspiratory (MIP) and expiratory muscle strength (MEP) was
measured using a hand-held mouth pressure device (Micro RMP;
Micro Medical, Rochester, UK). MIP was measured at residual lung
volume, whereas MEP was measured at total lung capacity10,17.
2.2.4. Peripheral muscle strength
Isometric quadriceps strengthwasdeterminedusing ahand-held
dynamometer (PowerTrack Commander II; JTECHMedical, Salt Lake
City, UT, USA) from both sides and the mean value was recorded18.
2.2.5. Exercise capacity
Functional exercise capacity was assessed using a 6-minute
walk test (6MWT) (ATS 2002). Heart rate (PF3000 heart rate
monitor; Polar Electro, Kempele, Finland), oxygen saturation
(KTPS-01 pulse oximeter; KTMed, Seoul, Korea), dyspnea, and fa-
tigue on a 10-point modiﬁed Borg scale were recorded before and
after the test. Two 6MWT tests at least 30 minutes apart were
performed to eliminate any potential learning effect. The test pro-
ducing the greater distance was used for analysis. The 6MWTresults are expressed in meters and percentage of the predicted
values19. The predicted maximum heart rate was calculated as 220
minus the patient’s age to determine the percentage maximum
heart rate reached at the end of the 6MWT20.
2.2.6. Physical activity
The level of physical activity was determined using the Turkish
version of the IPAQ. This is a seven-item questionnaire consisting of
list of activities, and requests estimates of the duration and fre-
quency for each activityengaged in over theprevious 7days12. Scores
for moderate and vigorous activities and walking were calculated as
the sum of the corresponding item scores in terms of duration
multiplied by knownmetabolic equivalents (METS) per activity. The
sitting question is a separate score and is not included in the physical
activity score. It represents the level of physical inactivity.
2.2.7. Multidimensional disease severity
Multidimensionaldisease severitywasmeasuredusing theBODE
index, consisting of airﬂow obstruction (FEV1), functional dyspnea
(MMRC dyspnea scale), exercise capacity (6MWT), and body mass
index21. For FEV1, 6MWT, and MMRC, a score of 1e3 points was
recorded; for bodymass index, the scorewas 0 or 1 point. The points
for each variable were added to obtain a score ranging from 0 to 10.
The BODE index has four severity stages: Stage I (score 0e2), Stage II
(score 3e4), Stage III (score 5e7), and Stage IV (score 8e10).
2.3. Statistical analysis
Statistical analysis was performed using Statistical Package for
Social Sciences (SPSS) version 15.0 (SPSS Inc., Chicago, IL, USA)22.
For descriptive analyses, data are presented as mean  SD unless
otherwise speciﬁed. Correlations were assessed using Pearson
correlation coefﬁcient analysis. Multiple linear regression was
performed using the IPAQ sitting score as the dependent variable
and variables signiﬁcantly related according to the correlation
analysis (p 0.015) as the independent variables. Probability values
of p < 0.05 were considered to be statistically signiﬁcant.
3. Results
The characteristics for the 30 study participants are presented in
Table 1. Their mean age was 66.87  4.31 years and the mean FEV1
Table 2




GOLD stage 0.517 0.268 0.268 98.053 0.434
Heart rate change 0.666 0.444 0.176 5.486 0.336
Orthopnea 0.732 0.536 0.092 140.289 0.321
a Dependent variable, IPAQ sitting score; independent variables (if p  0.015),
GOLD stage, change in heart rate during 6MWT, and orthopnea. R2 ¼ 0.536,
F(1,24)¼4.769, p ¼ 0.039, constant ¼ 721.259.
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follows: ﬁve (16.7%) patients in Stage I, nine (30%) patients in Stage
II, 12 (40%) patients in Stage III, and three (10%) patients in Stage IV.
According to multidimensional staging (BODE index), 17 patients
were in Stage I, seven in Stage II, four in Stage III, and one in Stage
IV. Twenty-seven (90%) patients had dyspnea and 24 (80%) had
fatigue at rest. Five (16.7%) patients had paroxysmal nocturnal
dyspnea and nine (30%) had orthopnea. Nine (30%) patients were
inactive, 17 (57%) were minimally active, and three (10%) were
sufﬁciently active (Table 2).
The IPAQ total score was signiﬁcantly related to MMRC
(r ¼0.38, p¼ 0.043), FEV1 (r ¼ 0.39, p ¼ 0.039), and FVC (r¼ 0.39,
p ¼ 0.039). The IPAQ moderate activity score was 140.00  261.00
METs/minute (0e1200 METs/minute) and it was signiﬁcantly
correlated with FEV1 (r ¼ 0.43, p ¼ 0.022), FEF25e75% (r ¼ 0.49,
p ¼ 0.009), and PEF (r ¼ 0.58, p ¼ 0.001). The mean IPAQ walking
score was 997.98  913.57 METs/minute (132e2772 METs/minute).
It was signiﬁcantly associated with MMRC (r ¼ 0.48, p ¼ 0.008),
FEV1/FVC (r ¼ 0.47, p ¼ 0.012), and exercise fatigue perception
(r ¼ 0.44, p ¼ 0.016).
In elderly COPD patients, the IPAQ sitting score was signiﬁcantly
related to 6MWT distance (r ¼ 0.51, p ¼ 0.004), GOLD stage
(r ¼ 0.52, p ¼ 0.005), paroxysmal nocturnal dyspnea (r ¼ 0.42,
p ¼ 0.023) and orthopnea (r ¼ 0.50, p ¼ 0.006), MMRC score
(r ¼ 0.40, p ¼ 0.031), FEV1 (r ¼ 0.48, p ¼ 0.009), FEV1/FVC
(r ¼ 0.47, p ¼ 0.012), FEF25e75% (r ¼ 0.43, p ¼ 0.021), PEF
(r ¼ 0.43, p ¼ 0.021), baseline heart rate (r ¼ 0.40, p ¼ 0.032),
change in heart rate during 6MWT (r ¼ 0.46, p ¼ 0.012), and
resting SpO2 (r ¼ 0.43, p ¼ 0.020). GOLD stage (Fig. 1), change in
heart rate during 6MWT, and orthopnea independently predicted
the IPAQ sitting score (R ¼ 0.732, R2 ¼ 0.536, F(1,24) ¼ 4.769,
p ¼ 0.039).
4. Discussion
The main ﬁnding of this study is that GOLD stage, orthopnea,
and change in heart rate during 6MWT independently predictedFig. 1. Regression analysis between physical inactivity and GOLD stage.the level of physical inactivity in elderly patients with COPD. These
three variables together explained 54% of the variance in physical
inactivity in elderly COPD.
COPD is characterized by airﬂow limitation that is progressive
and not fully reversible14. There are also some signiﬁcant extrap-
ulmonary effects that may contribute to disease severity14. The
GOLD staging system reﬂects the classiﬁcation of disease severity.
We found that disease severity according to GOLD stage made an
individual contribution to the level of physical inactivity in elderly
patients with COPD and explained 27% of the variance in daily
inactivity. An association between physical activity and disease
severity was observed in a previous study23. We found that the
amount of physical inactivity (sitting time) increased with disease
severity. An interaction with age could be extrapolated from this
observation, as both physical inactivity and disease severity in-
crease with age23.
Changes in heart rate during exercise reﬂect responses of the
sympathetic nervous system to increased metabolic demands24. In a
previous study, we showed that there is chronotropic incompetence
to maximal exercise in patients with COPD, mainly because of dys-
pnea25. In the present study, we used 6MWT to detect changes in
heart rate since it is ameasureof the submaximal sustainableexercise
capacity25 and is related to physical activity levels in COPD11. Changes
in heart rate during 6MWT explained 18% of the variance in physical
inactivity in our patients. Thisﬁnding indicates that nonphysiological
heart responses to exercise in COPD26 may be responsible for the
increased physical inactivity in elderly patients with COPD.
Patients with COPD often experience an increased sensation of
breathlessness in supine compared to sitting positions27. Increased
inspiratory resistive work is thought to be responsible for orthop-
nea in COPD patients28. In our study, orthopnea explained 9% of the
variance in physical inactivity. Since the BODE index was signiﬁ-
cantly related to orthopnea (r ¼ 0.46, p ¼ 0.012), its presence in
elderly patients with COPD may reﬂect higher multidimensional
disease severity.
There are few data on factors affecting sitting (sedentary) be-
haviors. COPD patients spend only 6 4% of the day inwalking11. In
our study, although 6MWT was correlated with the IPAQ sitting
score, it was not an independent contributor to physical inactivity.
Pitta et al found that 6MWT is the best indicator of physical activity
in COPD using activity monitors29. In our elderly patients, we used
activity recall for 7 days (IPAQ), and the discrepancy in the results
may be due to differences in methodology. Susceptibility to
misplacement and the high cost of accelerometers29 were the main
limitations for the use of these devices to monitor physical inac-
tivity in our elderly patients. Validated questionnaires such as the
IPAQ are inexpensive, easy to administer, and readily applicable for
measuring all kinds of habitual activity. However, they are based on
self-reports and hence are subject to both over- and underestima-
tion of physical activity levels29.
Physical inactivity may simply reﬂect disease severity. Physical
inactivity is a risk factor for pulmonary rehabilitation programs.
Participation in a pulmonary rehabilitation program of at least a
moderate physical activity level may offer protection from wors-
ening disability in elderly COPD patients30.
Proximal nocturnal dyspnea, theMMRC dyspnea score, FEF25e75%
and PEF, baseline heart rate, and resting SpO2 did not meet the
criteria for inclusion, and their independent contribution was not
calculated. The decrease in physical activity estimated in elderly
patients with COPD does not depend merely on the severity of
airﬂow limitation. We found no contribution of respiratory and pe-
ripheral muscle strength or body composition to physical inactivity.
We used a stepwise procedure to select medical and socio-
demographic variables in the model explaining variance in physical
inactivity. This approach ensured a conservative estimate of the
D. Inal-Ince et al.196unique contribution of demographic, physiological, physical, and
neurological factors in predicting physical inactivity, and limited
the type 1 error associated with multiple comparisons.
4.1. Study limitations
Several limitations of our study should be noted. The lack of
instrument validation for quantitative measures is a major limita-
tion. The IPAQ places little emphasis on assessing very low to
moderate levels of physical activity and short-term activities of less
than 10 minutes in duration. However, we measured physical
inactivity (sitting score) using the IPAQ questionnaire.
5. Conclusion
In conclusion, GOLD stage, change in heart rate during exercise,
and orthopnea are determinants of physical inactivity in elderly
COPD. Disease severity, chronotropic response, and positional
changes increased inspiratory resistive work caused by physical
inactivity. This information might facilitate physical activity man-
agement in patients with COPD.
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